Epidemiological determinants of COVID-19 infection and mortality: A study among patients presenting with severe acute respiratory illness during the pandemic in Bihar, India

被引:13
作者
Agarwal, Neeraj [1 ]
Biswas, Bijit [1 ]
Lohani, Pallavi [1 ]
机构
[1] All India Inst Med Sci, Dept Community & Family Med, Patna 801507, Bihar, India
关键词
COVID-19; diabetes; intensive care; mortality; severe acute respiratory illness;
D O I
10.4103/npmj.npmj_301_20
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The study was designed to explore epidemiological characteristics, determinants of COVID-19 infection development and mortality of patients presenting with severe acute respiratory illness (SARI) to a tertiary care health facility of Bihar. Methods: This was an observational record-based study, longitudinal in design. Data of 281 SARI patients who have attended All India Institute of Medical Sciences, Patna, Bihar, India during 25th April 2020, till 12th July 2020 (16 weeks) were used for the study. Results: Out of 281 study participants, 95 (33.8%) were detected to have COVID-19 and 42 (14.9%) died. Among COVID-positive study subject's death rate was 28.4%. In the multivariable logistic regression analysis; increasing age (adjusted odds ratio [AOR] = 1.02 [1.00-1.03]), gender (males) (AOR = 2.51 [1.27-4.96]), presenting symptom (cough) (AOR = 2.88 [1.46-5.70]), co-morbidity (hypothyroidism) (AOR = 4.59 [1.45-14.56]) and delay between symptom onset and admission (>2 days) (AOR = 2.46 [1.19-5.07]) were significant predictors of COVID-19 infection among study participants adjusted with other co-morbidities (diabetes and hypertension). Similarly, place of residence (outside Patna district) (AOR = 2.38 [1.03-5.50]), co-morbidity (diabetes) (AOR = 3.08 [1.12-8.50]), intensive care unit (ICU) requirement at admission (yes) (AOR = 9.47 [3.98-22.52]) and COVID status (positive) (AOR = 6.33 [2.68-14.96]) were significant predictors of death among the study participants whereas place of residence (outside Patna district) (AOR = 4.04 [1.33-12.28]) and ICU requirement at admission (yes) (AOR = 7.22 [2.54-20.52]) were attributes affecting death of COVID-positive study participants. Conclusion: Risk of COVID-19 infection among the study participants was high. Age, gender and co-morbidities increased the risk of infection. COVID-19 infection negatively impacted the treatment outcome of the study participants. Age, co-morbidity and ICU requirement were the other attributes affecting mortality.
引用
收藏
页码:293 / 301
页数:9
相关论文
共 17 条
[1]  
Aggarwal Amit, 2020, J Assoc Physicians India, V68, P19
[2]   Association Between Travel Distance, Hospital Volume, and Outcomes Following Resection of Cholangiocarcinoma [J].
Beal, Eliza W. ;
Mehta, Rittal ;
Hyer, J. Madison ;
Paredes, Anghela ;
Merath, Katiuscha ;
Dillhoff, Mary E. ;
Cloyd, Jordan ;
Ejaz, Aslam ;
Pawlik, Timothy M. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 23 (05) :944-952
[3]   Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? [J].
Fang, Lei ;
Karakiulakis, George ;
Roth, Michael .
LANCET RESPIRATORY MEDICINE, 2020, 8 (04) :E21-E21
[4]   Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020 [J].
Gupta, Nivedita ;
Praharaj, Ira ;
Bhatnagar, Tarun ;
Thangaraj, Jeromie Wesley Vivian ;
Giri, Sidhartha ;
Chauhan, Himanshu ;
Kulkarni, Sanket ;
Murhekar, Manoj ;
Singh, Sujeet ;
Gangakhedkar, Raman R. ;
Bhargava, Balram .
INDIAN JOURNAL OF MEDICAL RESEARCH, 2020, 151 (2-3) :236-240
[5]  
Health Department Government of Bihar., REGR SEV AC RESP ILL
[6]   Laboratory surveillance for SARS-CoV-2 in India: Performance of testing & descriptive epidemiology of detected COVID-19, January 22-April 30, 2020 [J].
Abraham P. ;
Aggarwal N. ;
Babu G.R. ;
Barani S. ;
Bhargava B. ;
Bhatnagar T. ;
Dhama A.S. ;
Gangakhedkar R.R. ;
Giri S. ;
Gupta N. ;
Kurup K.K. ;
Murhekar M. ;
Potdar V. ;
Praharaj I. ;
Rade K. ;
Reddy D.C.S. ;
Saravanakumar V. ;
Shah N. ;
Singh H. ;
Thangaraj J.W.V. ;
Yadav N. .
INDIAN JOURNAL OF MEDICAL RESEARCH, 2020, 151 (05) :424-437
[7]   Diabetes and metabolic syndrome as risk factors for COVID-19 [J].
Marhl, Marko ;
Grubelnik, Vladimir ;
Magdic, Marsa ;
Markovic, Rene .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (04) :671-677
[8]  
Ministry of Health & Family Welfare Directorate General of Health Services(EMR Division) Government of India, GUID CLIN MAN COVID
[9]  
National Centre for Disease Control Government of India, GUID CLIN MAN SEV AC
[10]  
Niquini RP, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311x00149420, 10.1590/0102-311X00149420]